3 hrs ago
One Reason Why CEL-SCI Has Become One Of 2014's Top Percentage...
Still, some argue that the firm's market cap is still undervalued and likely to continue higher given the fact that the companyA A's lead investigational immunotherapy, Multikine, is in the final stage of clinical trials for the treatment of primary head and neck cancer.
Trending on the Topix Network
Tue Mar 11, 2014
Report: HPV-related cancer in Iowa on the rise
Between 2006 and 2011, 2,107 cancers at sites related to the human papillomavirus were diagnosed in Iowa - a 24 percent increase over the total HPV-related cancers diagnosed between 1988 and 1993.
Global trends suggest HPV positive oral cancer greatly increased in young males
Role Objective: To independently manage Mitsubishi Motors Service Center operations to ensure high quality service to customers, achievement of expected service revenues and enhancing customer retention.
Mon Mar 10, 2014
Oxford Weekly News
Are these young people and their parents being properly informed that the co-inventor of the technology enabling the HPV vaccines, Professor Ian Frazer, has acknowledged that the risk of cancer associated with the HPV virus is very low? In an article on the university and CSIRO-funded The Conversation website, titled "Catch cancer? No thanks, I'd ... (more)
The Des Moines Register
HPV is causing cancers in Iowa men as well as women, new report says
A sexually transmitted virus normally associated with cervical cancer in women has also caused cancers in hundreds of Iowa men, a new report says.
Sat Mar 08, 2014
Vaccination against cervical cancer planned for 1.5 mln girls
In this 2010 file photo Rwandan vendors wait to sell bundles of wood at a morning market in Kigali, Rwanda.
Fri Mar 07, 2014
The Daily News Leader
Area health experts: Vaccines increasingly effective
As Dr. Steven W. Mumbauer reflected on the last decade-and-a-half or so of practicing pediatrics in the area, he noted a change.
Research and Markets: Adult and Adolescent Vaccines Market to 2018 -...
Pharmaceutical giants GlaxoSmithKline and Merck are fighting it out in the vaccination market, as countries pick sides in their cervical cancer vaccination programs.
Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation.
Human papillomavirus vaccine uptake in many countries has been sub-optimal. We examine several issues associated with non-vaccination that have received particular attention, including fears about sexual risk compensation, concerns about vaccine safety, inadequate vaccination recommendations by health care providers , and distrust due to the ... (more)
College women's HPV vaccine decision narratives.
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
San Antonio biotech firm readies skin treatment for distribution
ViroXis Corp. principals Paul Castella, Ian Clements and Corey Levenson are working to develop and bring to market an anti-wart compound made from sandalwood oil.
Thu Mar 06, 2014
Knowledge, awareness and attitudes about cervical cancer among women...
Cervical cancer is the first female cancer in Lao PDR, a low-income country with no national screening and prevention programs for this human papillomavirus associated pathology.
Wed Mar 05, 2014
The Winnipeg Free Press
Free-vaccine project to end
Jason Halstead / Winnipeg Free Press Dr. Denise Black says few doctors and fewer young women knew the HPV vaccine was available for free in the past 18 months.
Australian Broadcasting Corporation
Scientists reveal cervical cancer vaccine success
PETER LLOYD: A new study has shown that the Australian-developed cervical cancer vaccine is having a direct impact on the disease.
Tue Mar 04, 2014
Real-World HPV Study Finds Vaccine Protects Against Cervical Abnormalities
Vaccination with the quadrivalent human papillomavirus vaccine was associated with reduced risk for cervical abnormalities in young women presenting for their first cervical screening in Australia.
Genticel Reaches An Important Milestone By Launching Its Phase II...
Genticel, a biopharmaceutical company developing innovative therapeutic vaccines for patients infected with human papillomavirus , today announces that it has started a phase II study with its lead product ProCervix, a therapeutic vaccine designed to induce a curative cellular immune response in patients infected with HPV16 and/or HPV18.
Study Adds to Evidence That HPV Vaccine Helps Guard Against Cervical Cancer
A new study offers more evidence that the human papillomavirus vaccine is a powerful weapon in the fight against cervical cancer.
Study shows HPV vaccine saves lives
AUSTRALIA'S mass HPV vaccination program is working and saving lives, according to a study published in the British Medical Journal.
HPV vaccine provides significant protection against cervical abnormalities
The HPV vaccine offers significant protection against cervical abnormalities in young women, suggests a paper published on bmj.com today.
Global human papillomavirus infections market: Latest market analysis presented
This report provides information on the therapeutic development for Human Papillomavirus Infections, complete with latest updates, and special features on late-stage and discontinued projects.